The data forecasts a declining trend in the import of sulphonamides to France from 2024 to 2028, measured in thousand kilograms. The import value decreases annually, with 2024 starting at 898.87 and dropping to 673.29 by 2028. The year-on-year percentage change highlights a consistent decrease, indicating a shift towards a reduced dependence or alternative sourcing strategies. This results in a noticeable compound annual growth rate (CAGR) showing a negative trend over this period. In 2023, the actual import level was likely higher than the 2024 forecast start.
Future trends to watch for include potential shifts in pharmaceutical regulation within the EU, changes in domestic production capacities, and the impact of global trade agreements or restrictions, which could further influence the volume of sulphonamides imported by France.
